Minimally invasive glaucoma surgery, known as MIGS, has changed the way eye surgeons to restore a patient's vision. By creating a pathway through the eye, our experienced ophthalmologist surgeons at Vance Thompson Vision in Omaha, NE can implant an iStent Micro-Bypass device to aid in draining aqueous fluid naturally from the eye. The trabecular stent, iStent, is the smallest medical device ever implanted into humans to decrease eye pressure by creating a pathway in the high-resistance portion of the eye’s drainage system. The iStent was the first trabecular micro-bypass device approved by the FDA (summer 2012) and is the most thoroughly studied glaucoma device on the market today. At Vance Thompson Vision, ophthalmologist surgeon Dr. Brandon Baartman takes great care to select the right treatment for each glaucoma patient to lower intraocular pressure through comprehensive eye exams and testing. Learn more about MIGS and discover if iStent is the right choice for you.
"Very happy with the results, thanks"- D.B. / Facebook / Jun 05, 2019
"Friendly and Welcoming staff. The procedure was quick and painless."- C.B. / Facebook / Aug 24, 2020
"I was treated very well. Also covid protocol was excellent. Dr. and all assistants were very kind and attentive. This was a positive experience for me. Thank you all so much!!!"- S.H. / Facebook / Jul 14, 2020
"It was a great experience. It was a very warm and comfortable feeling from entering and meeting the front desk person to meeting with the Tech, Andrew. Dr. Goertz was a hoot. The days of my surgeries everyone was very welcoming. I felt very comfortable and everything was explained about what to expect before and after surgery. Dr. Baartman was wonderful. I felt safe in having the surgeries and the outcome was more than i hoped for. I would recommend VVC to everyone. Thank you."- M.D. / Facebook / Apr 15, 2021
"Very friendly, professional, high tech and knowledgeable. I highly recommend this office."- L.B. / Facebook / Apr 01, 2021
If you have been diagnosed with glaucoma (with or without cataracts), Dr. Baartman can make the determination if you are a great candidate for the iStent implant. We advise you to make an appointment for a consultation. Be prepared to review your list of current medications and answer a few questions regarding your medical and family health history.
Generally implanted during cataract surgery, the iStent implantation is an outpatient surgery performed at our Omaha office at Vance Thompson Vision. Our team will prep you for surgery with anesthetic (numbing) eye drops and a mild sedative if necessary. You will need to arrange for a ride home prior to surgery.
If you are also having a cataract excision, there will be no need for additional incisions to insert the implant. Measuring only 1 mm by .33 mm, the iStent is inserted into the trabecular meshwork of the eye (Schlemm's canal). When inserted into the eye, the small tube has been shown to increase the aqueous flow in the eye, which decreases the pressure within the eye and can decrease a patient’s reliance on glaucoma medication.
What to Expect
You can expect to have a few prescriptions to fill after your surgery to prevent infection and inflammation in your eyes. It is very important to follow all your post-surgical instructions and attend all follow-up appointments with your eye care provider. We will chart your intraocular pressure and make adjustments to your treatment as needed. If you have concerns or questions about iStent aftercare, we would be happy to assist you.
- Recovery Time
- 1 - 7 days
- Procedure Time
- 5 minutes
- Follow Up Time
- 1 day, 1 week, 1 month
- Recovery Location
envision Your iStent Treatment
Life without the constant worry about intraocular pressure damaging your optic nerve can be achieved with the right surgeon and treatment at Vance Thompson Vision in Omaha, NE. In addition, we will educate you on the other minimally invasive glaucoma surgeries (MIGS) available and answer any and all questions about this sight-saving device. Call and schedule your appointment with Dr. Baartman today.